Surgery may be best for advanced melanoma

April 5, 2017

(HealthDay)—Surgery to remove melanoma—the deadliest form of skin cancer—can extend the lives of patients whose disease has spread to the abdomen area, new research suggests.

Patients who get and to remove their cancer live twice as long—18 months on average—as those who only get medication, researchers found.

"Now that there are better options systemically, the decision-making about treatment has become more complex. Having this data available could potentially impact discussions about treatment and benefit long-term," said study leader Dr. Gary Deutsch, a cancer surgeon at Northwell Health in Great Neck, N.Y.

"I think the combination of immunotherapy with surgical therapy ... could potentially lead to curing more patients," he said in a health system news release.

Immunotherapy prompts a patient's immune system to destroy cancer cells. The U.S. Food and Drug Administration has approved it to treat melanoma, providing an alternative to standard chemotherapy for cancers that spread to other parts of the body. The researchers behind the new study said surgery to remove melanoma that has spread within the belly is rare.

For the study, Deutsch and his team analyzed the medical records of more than 1,600 patients treated for melanoma that had spread to the abdominal area. Of those, nearly 400 had surgery to remove their cancer.

Melanoma had spread to the liver in 697 patients, to the gastrointestinal tract in 336 patients and to the adrenal glands in 138 patients. It spread to the spleen in 109 patients and to the pancreas in 38. Another 305 patients' spread to several organs.

For patients who had surgery to remove their , the average survival time was 18 months, nearly 2.5 times longer than those who didn't have surgery.

The study was published April 5 in the journal JAMA Surgery.

Deutsch said he believes integrating surgery with newer drug treatments will greatly benefit patients.

Deutsch did the research as a surgical oncology fellow at the John Wayne Cancer Institute at Providence Saint John's Health Center in Santa Monica, Calif.

Explore further: Surgery on that has spread into abdomen more than doubles patient survival time

More information: The American Cancer Society provides more information on melanoma.

Related Stories

Surgery on that has spread into abdomen more than doubles patient survival time

October 8, 2015
Patients with metastatic melanoma who undergo surgery to remove lesions that have spread into the abdomen live more than twice as long as those treated with drug therapy alone, according to novel new research by a North Shore-LIJ ...

Liver tumor growth in mice slowed with new chemo-immunotherapy treatment

February 28, 2017
Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine ...

When breast cancer spreads to lungs, surgery may increase survival

April 1, 2013
(HealthDay)—Patients with breast cancer that has spread to the lungs may live longer if they have surgery to remove the lung tumors, a new study from Germany suggests.

Melanoma surgery delays are common for Medicare patients

April 8, 2015
One in five Medicare patients with melanoma experience delays in getting surgery, a Yale study found. The research was published April 8 in JAMA Dermatology.

Researchers find immunotherapy treatments better for advanced skin cancer

November 4, 2016
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival ...

Research providing promising new treatments for melanoma

December 6, 2016
In a paper published online November 30, 2016, in Melanoma Management, Adam Riker, MD, Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.